IP Library Granted Patent US 10,167,490
Granted Patent B2
US 10,167,490 · App. 14/428,061 · Granted Jan 1, 2019

Ergothioneine production through metabolic engineering

Inventors: Pinghua Liu (Newton, MA); Heng Song (Allston, MA); Wen Hu (Boston, MA)
Assignee: Ergo Health LLC
C12P17/10C07D233/42C12N15/52C12P13/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,167,490
App. No.
14/428,061
Granted
Jan 1, 2019
Kind
B2
Abstract

The present disclosure relates to the production of ergothioneine through either in vitro enzymatic transformations or fermentations using microbials created by metabolic engineering. Also disclosed are transformed cells useful in such methods and ergothioneine produced by such methods. Transformed cells of the disclosure are capable of converting histidine and cysteine or hercynine and cysteine into ergothioneine in greater efficiency than the untransformed wild-type cells.

Claims (24)

1. A process for preparing ergothioneine, the process comprising:

(i) incubating histidine or hercynine with a reaction mixture comprising recombinantly expressed:

(a) EgtA protein,

(b) EgtB protein,

(c) EgtC protein,

(d) EgtD protein, and

(e) EgtE protein, wherein the EgtE protein is produced from recombinant coexpression with a gene encoding a FAD synthetase to facilitate EgtE production; and

(ii) isolating ergothioneine from the reaction mixture.

2. A process for preparing ergothioneine, the process comprising:

(i) incubating hercynine with a reaction mixture comprising recombinantly expressed:

(a) OvoA protein and

(b) EgtE protein; and

(ii) isolating ergothioneine from the reaction mixture.

3. A process of claim 2 , wherein the reaction mixture further comprises recombinantly expressed EgtD protein.

4. The process of claim 1 , wherein the EgtD protein is recombinantly co-expressed with a gene encoding SAM synthetase.

5. The process of claim 1 , wherein the enzymatic mixture further comprises methionine or cysteine.

6. The process of claim 1 , wherein the enzymatic mixture further comprises an iron salt.

7. The process of claim 1 , wherein the reaction mixture comprises a cell lysate.

8. A process for preparing ergothioneine, the process comprising:

(i) incubating hercynine with a reaction mixture comprising recombinantly expressed:

(a) NcEgt1 protein and

(b) EgtE protein, wherein the EgtE protein is produced from recombinant coexpression with a gene encoding a FAD synthetase to facilitate EgtE production; and

(ii) isolating ergothioneine from the reaction mixture.

9. A process of claim 8 , wherein the reaction mixture further comprises recombinantly expressed EgtD protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2018
From: LIU, PINGHUA; SONG, HENG; HU, WEN
To: ERGO HEALTH LLC
Reel/Frame 047489/0968 →
Continuity (2)
Provisional Application 61740829 · Dec 21, 2012
Related Publication 20150225755A1 · Aug 13, 2015